Showing 3191-3200 of 7638 results for "".
- Revian Awarded Patent for Biostimulatory Light Combinationshttps://practicaldermatology.com/news/revian-awarded-patent-for-biostimulatory-light-technology/2460249/Revian Inc. has received from the United States Patent and Trademark Office (USPTO) U.S. Patent No. 10,265,258—the seminal patent on the use of proprietary color combinations of light to regenerate living tissue in the body. The claims in this issued patent cover the use of specific wavelengths …
- It’s Gold and Silver for Sebacia with Sienna Acquisitionhttps://practicaldermatology.com/news/its-gold-and-silver-for-sebacia-with-sienna-acquisition/2460247/Mr. Chuck Abraham is the new Chief Executive Officer of Sebacia, Inc. Sebacia is preparing a targeted commercial launch of Sebacia Microparticles in the US for treatment of acne early in 2020 with plans to expand to additional territories later in the year. In addition, Sebacia acquired all asset…
- The HydraFacial Company Takes on Scalp Healthhttps://practicaldermatology.com/news/the-hydrafacial-company-takes-on-scalp-health/2460245/The HydraFacial Company is launching HydraFacial Keravive, a treatment designed to cleanse, stimulate, nourish and hydrate the scalp for fuller and healthier-looking hair. The new treatment uses vortex technology and Keravive Peptide Complex Solution to cleanse, exfoliate, stimulate, and deliver a…
- P&G to Unveil Improved Opte Precision Skincare System at CES 2020https://practicaldermatology.com/news/pg-to-unveil-improved-opte-precision-skincare-system-at-ces-2020/2460243/P&G Ventures, the startup studio within Procter & Gamble, is slated to showcase the Opte Precision Skincare System, the first personalized handheld inkjet printer to instantly make the appearance of skin's hyperpigmentation disappear and fade spots over time, at CES 2020. CES 2020 will take place …
- BTL Files Patent Infringement Lawsuit Against Allergan and Zimmer Related to Emsculpthttps://practicaldermatology.com/news/btl-files-patent-infringement-lawsuit-against-allergan-and-zimmer-related-to-emsculpt-1/2460239/BTL Aesthetics' US affiliate has filed a lawsuit against Allergan plc, Ireland and its affiliates, and Zimmer MedizinSysteme GmbH, Germany, and its affiliate, in the US Federal District Court for the District of Delaware. The lawsuit asserts that the Cooltone device, manufactured by Zimmer for Al…
- FDA Approves Ortho Dermatologic’s Arazlo Lotion for Acnehttps://practicaldermatology.com/news/fda-approves-ortho-dermatologics-arazlo-lotion-for-acne/2460238/The FDA has approved the New Drug Application for ARAZLO (tazarotene) Lotion, 0.045%, for the topical treatment of acne vulgaris in patients nine years of age and older. Ortho Dermatologic’s ARAZLO is the first tazarotene acne treatment available in a lotion form, and has been shown to provide st…
- New Anti-Acne Launches from Ceravehttps://practicaldermatology.com/news/new-launches-from-cerave/2460236/CeraVe is rolling out Acne Foaming Cream Cleanser with Benzoyl Peroxide and a Resurfacing Retinol Serum. "Acne is a common skin concern that affects millions of people both physically and emotionally," says Derrick Booker, vice president of marketing at CeraVe, in a news release. "As the number on…
- Castle Creek Completes Acquisition of Fibrocell Sciencehttps://practicaldermatology.com/news/castle-creek-completes-acquisition-of-fibrocell-science/2460235/Castle Creek Pharmaceutical Holdings, Inc. completed the acquisition of Fibrocell Science, Inc. Both companies have advanced investigational therapies for the treatment of epidermolysis bullosa (EB) into late-stage clinical research. Prior to the acquisition, Fibrocell initiated a pivotal Phase 3 …
- AAD/NPF Guidelines Address Pediatric PsOhttps://practicaldermatology.com/news/aadnpf-guidelines-address-pediatric-pso/2460234/New guidelines from the American Academy of Dermatology and the National Psoriasis Foundation offer counsel on how to best manage psoriasis and its extracutaneous manifestations in children and adolescents. The 2019 guidelines of care for the management and treatment of psoriasis in pediatric pati…
- Defective Stem Cell Behavior Linked to Psoriasishttps://practicaldermatology.com/news/defective-stem-cell-behavior-linked-to-psoriasis/2460233/Investigators from Brigham and Women’s Hospital and the Harvard Stem Cell Institute have uncovered a novel pathway that may explain why skin thickens in psoriasis and suggests new strategies for developing therapies for the condition. The team’s results are published in the Journal of Investigativ…